Scientific paper - Letter
Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab
Clinical and Experimental Dermatology, 46 (2021), 8; 1572-1573. https://doi.org/10.1111/ced.14757


Cite this document

Hlača, N., Žagar, T., Kaštelan, M., Brajac, I. & Prpić Massari, L. (2021). Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab. Clinical and Experimental Dermatology, 46. (8), 1572-1573. doi: 10.1111/ced.14757

Hlača, Nika, et al. "Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab." Clinical and Experimental Dermatology, vol. 46, no. 8, 2021, pp. 1572-1573. https://doi.org/10.1111/ced.14757

Hlača, Nika, Tina Žagar, Marija Kaštelan, Ines Brajac and Larissa Prpić Massari. "Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab." Clinical and Experimental Dermatology 46, no. 8 (2021): 1572-1573. https://doi.org/10.1111/ced.14757

Hlača, N., et al. (2021) 'Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab', Clinical and Experimental Dermatology, 46(8), pp. 1572-1573. doi: 10.1111/ced.14757

Hlača N, Žagar T, Kaštelan M, Brajac I, Prpić Massari L. Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab. Clinical and Experimental Dermatology [Internet]. 2021 June 24 [cited 2024 March 28];46(8):1572-1573. doi: 10.1111/ced.14757

N. Hlača, T. Žagar, M. Kaštelan, I. Brajac and L. Prpić Massari, "Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab", Clinical and Experimental Dermatology, vol. 46, no. 8, pp. 1572-1573, June 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:866990. [Accessed: 28 March 2024]